Showing results (231-240 of 276) with videos related to
Sort By:
Pageof 28
Clinical Science (London, England : 1979)|June 1, 1984
Effect of alcohol withdrawal on blood pressure, plasma renin activity, aldosterone, cortisol and dopamine beta-hydroxylaseL T Bannan, J F Potter, D G Beevers, et al.Journal of Human Hypertension|June 26, 2002
Oxidative stress in malignant and non-malignant phase hypertensionG Y H Lip, E Edmunds, S L Nuttall, et al.Journal of Neurosurgery|June 1, 1986
Reduced platelet function in subarachnoid hemorrhageS A Tsementzis, J S Gill, E R Hitchcock, et al.Archives of Internal Medicine|April 1, 1989
A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study)M Julius, J D Kneisley, P Carpentier-Alting, et al.Journal of the American Society of Nephrology : JASN|December 1, 1991
Geographic variation in the incidence of treated end-stage renal diseaseB Foxman, L H Moulton, R A Wolfe, et al.BMJ (Clinical Research Ed.)|December 7, 1996
Association of cardiovascular disease risk factors with socioeconomic position during childhood and during adulthoodD Blane, C L Hart, G D Smith, et al.Journal of Human Hypertension|September 17, 2004
The financial cost of optimising blood pressure controlT Shiner, L Simons, H Parkinson, et al.Circulation|August 1, 1996
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirinG Y Lip, P L Lip, J Zarifis, et al.QJM : Monthly Journal of the Association of Physicians|June 8, 2001
Dyslipidaemia in patients with malignant-phase hypertensionE Edmunds, M J Landray, F L Li-Saw-Hee, et al.The Quarterly Journal of Medicine|July 1, 1976
Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronismD G Beevers, J J Brown, J B Ferriss, et al.Pageof 28